CO
Christopher Ogden (Chief Financial Officer) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in CytomX Therapeutics, Inc. (CTMX). The largest single filing was $124K of CTMX (19,323 sh × $6.42, as filed), executed Mar 17. Data as of Nov 7 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$124K
shares × price, as filed
Last traded
Mar 17
Filed Mar 19
Median ADV $7.6M across their filed names
Open performance→Volume by month
Buys $0
Sells $124K
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
CTMXRecent filings
CTMXSALE
CytomX Therapeutics, Inc.
View filing →
$124K19,323 sh × $6.42
Exec Mar 17
Filed Mar 19 · 5:30 PM ET